Work

Phase II trial of bolus 5-FU/l-LV regimen as salvage line chemotherapy for oral fluorouracil resistant unresectable gastric cancer (HGCSG1502).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.4_suppl.tps177

Authors: Tetsuhito Muranaka, Satoshi Yuki, Kentaro Sawada, Yasuyuki Kawamoto, Hiroshi Nakatsumi, Masayoshi Dazai, Hideyuki Hayashi, Michio Nakamura, Atsushi Ishiguro, Susumu Sogabe, Yoshimitsu Kobayashi, Takuto Miyagishima, Ichiro Iwanaga, Miki Tateyama, Kazuteru Hatanaka, Takashi Kato, Naoya Sakamoto, Yuh Sakata, Yoshito Komatsu

Institutions: Hokkaido University Hospital, Abashiri-Kosei General Hospital, Sapporo City General Hospital, Teine Keijinkai Hospital, Kushiro Rosai Hospital, Japanese Red Cross Kitami Hospital, Hakodate Municipal Hospital, Hokkaido Gastroenterology Hospital, Misawa City Hospital

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589567965

Cites:

Cited by: 1

Related to: 10